MoneyWorks4Me

Biocon informs about disclosure

18 Aug 2026 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Announces U.S. FDA Approval for Yesintek® (ustekinumab-kfce) Single-dose Prefilled Autoinjector’. The above information will also be available on the website of the Company at www.biocon.com

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..